Baseline viral load - a predictor of treatment response in advanced hepatitis C

@inproceedings{Ivanova2013BaselineVL,
  title={Baseline viral load - a predictor of treatment response in advanced hepatitis C},
  author={I. Ivanova and I. Kotsev and M. Atanassova and A. Atanassova and B. Manevska and Ivan Y. Krasnaliev and T. Chervenkov and S. Balev},
  year={2013}
}
PURPOSE: The stage of liver disease and genotype of hepatitis C virus (HCV) are well-defined predictors for therapeutic success in chronic hepatitis C. This study aimed at assessing the prognostic role of baseline viral load for response to antiviral therapy in genotype 1 infected patients. MATERIAL AND METHODS: The study covered a total of 163 patients with hepatitis C, 93 of them with absent, mild or septal fibrosis (F0-F2) and 70 cases with bridging fibrosis (F3) or cirrhosis (F4). Viral… Expand
View via Publisher
journals.mu-varna.bg
1 Citations

One Citation

Citation Type

Citation Type

Role of serum level and genetic variation of IL-28B in interferon responsiveness and advanced liver disease in chronic hepatitis C patients
  • 12

References

SHOWING 1-10 OF 22 REFERENCES
Predicting the therapeutic response in patients with chronic hepatitis C: the role of viral kinetic studies.
  • P. Ferenci
  • Medicine
  • The Journal of antimicrobial chemotherapy
  • 2004
  • 83
  • PDF
Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing.
  • 46
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α‐2a (40 kd)/ribavirin therapy
  • 523
Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial
  • 304
Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus.
  • 729
  • PDF
Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: a randomized controlled trial.
  • 101
Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.
  • K. Lindsay, C. Morishima, +8 authors M. Ghany
  • Medicine
  • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2008
  • 30
Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population
  • 54
Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial
  • 267
  • PDF
Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C.
  • 14
...
1
2
3
...